Clinical Trial Update: Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating combined IVIG-SN 10% and acetylsalicylic acid in Kawasaki disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Acetylsalicylic acid (Aspirin)
• IVIG-SN 10%

Snippet

Sponsor: Green Cross Corporation | Conditions: Kawasaki Disease | Phase 4 | Status: COMPLETED